about
Cytologic Features of ALK-Positive Pulmonary Adenocarcinoma.The determination of relationship between "excision repair cross-complementing group 1" (ERCC1) gene T19007C and C8092A single nucleotide polymorphisms and clinicopathological parameters in non-small cell lung cancer.Identification of microRNA differentially expressed in three subtypes of non-small cell lung cancer and in silico functional analysis.MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway.Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology.[Immunohistochemical detections of EGFR status in NSCLC].
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeted Therapies in Lung Cancer.
@ast
Targeted Therapies in Lung Cancer.
@en
Targeted Therapies in Lung Cancer.
@nl
type
label
Targeted Therapies in Lung Cancer.
@ast
Targeted Therapies in Lung Cancer.
@en
Targeted Therapies in Lung Cancer.
@nl
prefLabel
Targeted Therapies in Lung Cancer.
@ast
Targeted Therapies in Lung Cancer.
@en
Targeted Therapies in Lung Cancer.
@nl
P2860
P1476
Targeted Therapies in Lung Cancer.
@en
P2093
Lucian R Chirieac
Sanja Dacic
P2860
P356
10.1016/J.PATH.2010.04.001
P577
2010-03-01T00:00:00Z